IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
Post-LOEibuprofen and pseudoephedrine hcl
ANDAORALCAPSULE
Approved
Dec 2017
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE (ibuprofen and pseudoephedrine hcl) by Aurobindo Pharma is cyclooxygenase inhibitors [moa]. Approved for nonsteroidal anti-inflammatory drug [epc]. First approved in 2017.
Drug data last refreshed 21h ago
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets
Started Apr 2014
66 enrolled
Pain, HeadPain, AcutePain, Back+1 more
Company
Worked on IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.